Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Improved biological insight and influence on management in indolent lymphoma. Talk 3: update on nodal and splenic marginal zone lymphoma.

Hematology. American Society of Hematology. Education Program - 8 Dec 2017

Thieblemont Catherine

Abstract excerpt

Splenic marginal zone lymphoma (SMZL) and nodal marginal zone lymphoma (NMZL) are rare indolent chronic B-cell lymphomas. Prognosis is typically good with median survival around 10-15 years. Management is generally based on the presence of symptoms or high tumor burden. There are no standard treatments for these 2 entities, and therapeutic strategies are rapidly evolving. Clinical developments for these 2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenine
Share to Lenalidomide
Share to Lymphoma, B-Cell, Marginal Zone

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Piperidines

Share to Pyrazoles

Share to Rituximab

Share to Splenic Neoplasms

Share to Thalidomide

Source

Open in PubMed Open full text

Identifiers

PMID: 29222281
DOI: 10.1182/asheducation-2017.1.371
PMCID: PMC6142593

Genes

BCL2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Improved biological insight and influence on management in indolent lymphoma. Talk 3: update on nodal and splenic marginal zone lymphoma.PMID 29222281Read ↗

Optimizing therapy for nodal marginal zone lymphomaSemantic proximity Read ↗

The biology of marginal zone lymphoma subtypes: challenge and relevance of classification.Semantic proximity Read ↗

New Insights into the Biology and Diagnosis of Splenic Marginal Zone LymphomasSemantic proximity Read ↗

Nodal marginal zone lymphoma.Semantic proximity Read ↗

NOTCH signaling in the pathogenesis of splenic marginal zone lymphoma-opportunities for therapy.Semantic proximity Read ↗

Genetic and phenotypic attributes of splenic marginal zone lymphoma.Semantic proximity Read ↗

Splenic marginal zone lymphoma: current knowledge and future directions.Semantic proximity Read ↗

Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification.Semantic proximity Read ↗

Marginal zone lymphomasSemantic proximity Read ↗

NF-κB deregulation in splenic marginal zone lymphoma.Semantic proximity Read ↗

Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targetsSemantic proximity Read ↗

Splenic marginal zone lymphoma: from genetics to management.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.